Prevalence Of Positive Quantiferon-Tb Gold In-Tube Test In Uveitis And Its Clinical Implications In A Country Non-Endemic For Tuberculosis.
To report on the prevalence and clinical implications of positive QuantiFERON-Gold (QFT-G) test results in the diagnostic work-up of a large cohort of consecutive patients with uveitis in the Netherlands. Retrospective cross-sectional study. This study included 710 consecutive patients who all underwent work-up for uveitis including QFT-G testing. The ocular features, comorbidity and abnormalities in diagnostic imaging and laboratory tests were registered for QFT-G positive patients with uveitis. Out of all patients, 13% (92/710) were positive for QFT-G. Prior treated TB was documented only in 2 patients. Out of all 92 QFT- G positive patients, culture-proven active TB was observed only in one case. The proportion of patients with uveitis of unknown etiology was higher in QFT-G positive than in the QFT-G negative patients (54/92; 59% vs. 238/618; 39%, P=0.0004). The uveitis features of the QFT-G positive patients were mainly nonspecific. Out of all QFT-G positive patients with uveitis, 17 patients had chest-imaging changes suggesting either TB or sarcoidosis. Twenty-nine of QFT-G positive patients with otherwise unexplained uveitis completed anti-tuberculous therapy (29/710; 4% of all included patients) with beneficial effect in the majority of cases. The QFT-G tested positive in 13% of patients with uveitis in the Netherlands, whilst only sporadic patients had a documented prior or active TB. The proportion of patients with unexplained uveitis was higher in QFT-G positive patients. Though the association between uveitis and positive QFT-G test might be coincidental, the majority of treated QFT-G positive patients with otherwise unexplained severe uveitis cause showed a beneficial response to anti-tuberculous therapy.